Literature DB >> 21270062

Tumour marker requesting in primary care and the role of the laboratory.

Patrick L C Walker1, Martin Crook.   

Abstract

AIMS: To review the incidence of multiple tumour marker (TM) requesting in the primary care setting and determine whether the rationale for requesting a TM panel is in agreement with evidence-based guidelines.
METHODS: Data-mining software was used to retrospectively identify multiple TM requests and requesting practices of GP surgeries over a 34-month period for α-fetoprotein, CA125, CA15-3, CA19-9, carcinoembryonic antigen and prostate-specific antigen. The appropriateness of each test was reviewed by a clinical biochemist in accordance with National Association of Clinical Biochemistry best-practice guidelines.
RESULTS: 505 multiple TM requests were identified which corresponded to 1304 TM tests. Comparison with best-practice guidelines suggested that 68% of request cards contained no appropriate TM request, and 84% of the tests requested were inappropriate.
CONCLUSION: A review of requesting practices in primary care for TMs highlights the need for laboratories to be more proactive in educating their users on their clinical utility and limitations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270062     DOI: 10.1136/jcp.2010.085357

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach.

Authors:  Adam C Seegmiller; Annette S Kim; Claudio A Mosse; Mia A Levy; Mary Ann Thompson; Megan K Kressin; Madan H Jagasia; Stephen A Strickland; Nishitha M Reddy; Edward R Marx; Kristy J Sinkfield; Herschel N Pollard; W Dale Plummer; William D Dupont; Edward K Shultz; Robert S Dittus; William W Stead; Samuel A Santoro; Mary M Zutter
Journal:  Am J Clin Pathol       Date:  2013-11       Impact factor: 2.493

2.  Appropriateness of tumor marker request: a case of study.

Authors:  Massimo Gion; Chiara Trevisiol; Aline S C Fabricio
Journal:  Ann Transl Med       Date:  2017-07

3.  CLEIA CA125 evidences: good analytical performance avoiding "Hook effect".

Authors:  R Falzarano; V Viggiani; S Michienzi; B Colaprisca; F Longo; L Frati; E Anastasi
Journal:  Tumour Biol       Date:  2012-11-01

4.  Injudicious use of laboratory facilities in tertiary care hospitals at Rawalpindi, Pakistan: a cross-sectional descriptive study.

Authors:  Muhammad Farooq Malik; Dilshad Ahmed Khan; Wafa Munir Ansari; Farooq Ahmad Khan
Journal:  BMC Health Serv Res       Date:  2013-11-26       Impact factor: 2.655

5.  Screening Circulating Tumor Cells as a Noninvasive Cancer Test in 3388 Individuals from High-Risk Groups (ICELLATE2).

Authors:  Juan Castro; Luis Sanchez; María Teresa Nuñez; Ming Lu; Tomas Castro; Hamid R Sharifi; Christer Ericsson
Journal:  Dis Markers       Date:  2018-05-28       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.